Signaling through the extracellular signal-regulated kinase 1/2 cascade in cardiac myocytes
- PMID: 15674427
- DOI: 10.1139/o04-110
Signaling through the extracellular signal-regulated kinase 1/2 cascade in cardiac myocytes
Abstract
The extracellular signal-regulated kinases 1/2 (ERK1/2) are particularly implicated in the growth response of cardiac myocytes. In these cells, the ERK1/2 pathway is potently activated by Gq protein-coupled receptor agonists (such as endothelin-1 or alpha-adrenergic agonists), which activate protein kinase C isoforms. Here, we review the mechanisms associated with the activation of the ERK1/2 pathway by these agonists with particular emphasis on signal integration into the pathway. Signaling to the nucleus and the regulation of transcription factor activity associated with ERK1/2 activation in cardiac myocytes are also discussed.
Similar articles
-
Peptide growth factors signal differentially through protein kinase C to extracellular signal-regulated kinases in neonatal cardiomyocytes.Cell Signal. 2006 Feb;18(2):225-35. doi: 10.1016/j.cellsig.2005.04.005. Epub 2005 Jun 3. Cell Signal. 2006. PMID: 15936927
-
Functionally opposing roles of extracellular signal-regulated kinase 1/2 and p38 mitogen-activated protein kinase in the regulation of cardiac contractility.Circulation. 2008 Oct 14;118(16):1651-8. doi: 10.1161/CIRCULATIONAHA.107.758623. Epub 2008 Sep 29. Circulation. 2008. PMID: 18824646
-
Using U0126 to dissect the role of the extracellular signal-regulated kinase 1/2 (ERK1/2) cascade in the regulation of gene expression by endothelin-1 in cardiac myocytes.J Mol Cell Cardiol. 2006 Aug;41(2):236-47. doi: 10.1016/j.yjmcc.2006.04.011. Epub 2006 Jun 6. J Mol Cell Cardiol. 2006. PMID: 16756989
-
A new G(q)-initiated MAPK signaling pathway in the heart.Dev Cell. 2009 Feb;16(2):163-4. doi: 10.1016/j.devcel.2009.01.021. Dev Cell. 2009. PMID: 19217418 Review.
-
The ERK1/2 mitogen-activated protein kinase pathway as a master regulator of the G1- to S-phase transition.Oncogene. 2007 May 14;26(22):3227-39. doi: 10.1038/sj.onc.1210414. Oncogene. 2007. PMID: 17496918 Review.
Cited by
-
α₁ adrenoceptor activation by norepinephrine inhibits LPS-induced cardiomyocyte TNF-α production via modulating ERK1/2 and NF-κB pathway.J Cell Mol Med. 2014 Feb;18(2):263-73. doi: 10.1111/jcmm.12184. Epub 2013 Dec 5. J Cell Mol Med. 2014. PMID: 24304472 Free PMC article.
-
Functional modulation of sarcolemmal KATP channels by atrial natriuretic peptide-elicited intracellular signaling in adult rabbit ventricular cardiomyocytes.Am J Physiol Cell Physiol. 2020 Jul 1;319(1):C194-C207. doi: 10.1152/ajpcell.00409.2019. Epub 2020 May 20. Am J Physiol Cell Physiol. 2020. PMID: 32432931 Free PMC article.
-
Nesfatin-1 as a novel cardiac peptide: identification, functional characterization, and protection against ischemia/reperfusion injury.Cell Mol Life Sci. 2013 Feb;70(3):495-509. doi: 10.1007/s00018-012-1138-7. Epub 2012 Sep 7. Cell Mol Life Sci. 2013. PMID: 22955491 Free PMC article.
-
Mitogen-activated protein kinases in heart development and diseases.Circulation. 2007 Sep 18;116(12):1413-23. doi: 10.1161/CIRCULATIONAHA.106.679589. Circulation. 2007. PMID: 17875982 Free PMC article. Review.
-
ERK: A Key Player in the Pathophysiology of Cardiac Hypertrophy.Int J Mol Sci. 2019 May 1;20(9):2164. doi: 10.3390/ijms20092164. Int J Mol Sci. 2019. PMID: 31052420 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Miscellaneous